Retrophin, Inc. (OTCQB: RTRX) today announced that it has named Marc L.
Panoff, CPA, MBA as Chief Financial Officer and Chief Accounting
Officer, effective May 20. Retrophin is ... read more
Retrophin, Inc. (OTCQB: RTRX), a biotechnology company focused on the
discovery and development of orphan drugs for the treatment of rare and
life-threatening diseases for which there are ... read more
Retrophin, Inc. (OTCQB: RTRX), a biotechnology company focused on the
discovery and development of orphan drugs for the treatment of rare and
life-threatening diseases for which there are ... read more
Retrophin, Inc. (OTCQB: RTRX), a biotechnology company focused on the
discovery and development of orphan drugs for the treatment of rare and
life-threatening diseases for which there are ... read more
Desert Gateway (OTCPK: RTRX), the parent company of Retrophin, Inc., a
biotechnology company focused on discovering and developing treatments
for rare and life-threatening diseases, today announced it has ... read more
Retrophin, Inc., a biotechnology company focused on discovering and
developing treatments for rare and life-threatening diseases, today
announced the successful completion of its merger with Desert Gateway,
... read more